FME Germany: Xetra


    FME XE
    Last Updated: Sep 9, 2022 6:30 p.m. CEDT Delayed quote


    1.02 3.15%
    Previous Close
    Advanced Charting
    Volume: 784.75K 65 Day Avg: 810.34K
    97% vs Avg
    32.21 Day Range 33.42
    32.21 52 Week Range 63.66

    Your Watchlists

    Customize 江湖电竞最新版比赛(江湖电竞投注app网站)

    Have Watchlists? Log in to see them here or sign up to get started.

    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    No Saved Watchlists

    Create a list of the investments you want to track.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    FME Overview

    Key Data

    • Open €32.50
    • Day Range 32.21 - 33.42
    • 52 Week Range 32.21 - 63.66
    • Market Cap €9.5B
    • Shares Outstanding 293.41M
    • Public Float 199.01M
    • Beta 0.58
    • Rev. per Employee €149.65K
    • P/E Ratio 12.14
    • EPS €2.75
    • Yield 4.04%
    • Dividend €1.35
    • Ex-Dividend Date May 13, 2022
    • Short Interest N/A
    • % of Float Shorted N/A
    • Average Volume 810.34K


    5 Day
    • -2.60%
    1 Month
    • -8.89%
    3 Month
    • -34.56%
    • -41.56%
    1 Year
    • -45.95%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 18 Full Ratings

    Recent News

    Fresenius SE 2Q Sales EUR10.02B

    Fresenius, Fresenius Medical Care Shares Tumble on Warnings

    Fresenius Lowers 2022 Outlook on Fresenius Medical Care Warning

    Read full story

    Investors can bet on whether people will get fit, fat, or old with these ETFs

    Read full story

    Fresenius Turns Defense to Offense

    Fresenius raises dividend as net profit drops

    FRANKFURT--German health-care products and services company Fresenius SE & Co. KGaA on Wednesday reported a decline in fourth-quarter net profit but raised its dividend for the year by 6% after strong full-year results dri...

    Fresenius sales rise, 2013 outlook confirmed

    Fresenius SE & Co. KGaA (FRE.XE) confirmed full-year guidance after all business segments contributed to increased sales in the third quarter. Sales rose to 5.05 billion euros ($6.82 billion) in the third quarter from EUR4...

    No Headlines Available

    Fresenius Medical Care AG & Co. KGaA

    Fresenius Medical Care AG & Co. KgaA provides products and services for individuals with renal diseases. The firm develops and manufactures health care products, which includes dialysis and non-dialysis products. It operates through the following segments: North America Segment; EMEA Segment; Asia-Pacific Segment; and Latin America Segment. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.


    Name Chg % Market Cap
    Fresenius SE & Co. KGaA 4.17% €13.65B
    Baxter International Inc. 0.31% CHF35.47B
    Eifelhoehen-Klinik AG 57.14% €13.28M
    MediClin AG -0.63% €151.05M